Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Risk Of Frailty In Older Women Dependent On Multisystem Abnormalities
A study published online ahead of press in the Gerontology Society of America"s Journal of Gerontology: Medical Sciences reports that the condition of frailty in older adults is associated with a critical mass of abnormal physiological systems, over and above the status of each individual system, and that the relationship is nonlinear. This research is the first evidence that frailty is related to the number of abnormal physiological systems, rather than a specific system abnormality, a chronic disease, or chronological age. It suggests significant alterations in system biology with aging, and underlying frailty. Clinical implications are that prevention and treatment may be more likely to be effective if any given intervention improves multiple systems, not just one.
generic viagra online
Royal Pharmaceutical Society Calls For Older People To Review Their Medicine With A Pharmacist
New research released by the Royal Pharmaceutical
News of the day
Gender Difference In Heart Failure
Striking differences in the risk factors for developing heart failure (HF) and patient prognosis exist between men and women. Men and women may also respond differently to treatment, raising concerns about whether current practices provide the best care and reinforcing the urgency for sex-specific clinical trials for HF, according to a review article published in the August 4, 2009, issue of the Journal of the American College of Cardiology.
Health Insurance

BIO Commends NIH On New Stem Cell Research Guidelines

The Biotechnology Industry Organization released the following statement in response to the National Institutes of Health"s (NIH) final guidelines on federal funding of stem cell research, which includes embryonic stem cell research. The new guidelines go into effect today. These comments can be attributed to Jim Greenwood, President and CEO of BIO. "We commend the NIH for recognizing the importance of stem cell research to develop innovative biotechnology medicines to treat and cure debilitating and life-threatening diseases, such as diabetes, Parkinson"s and spinal cord injuries. "These guidelines allow for federal funding to support this research, which is critical for enabling biotechnology companies to continue to aggressively develop innovative products that are so desperately needed by patients. We believe that research on both adult and embryonic stem cells holds great promise to produce new therapies and possibly cures for the millions of patients in the U.S. and around the world suffering from cancer, diabetes, Alzheimer"s, Parkinson"s, spinal cord injuries and other life-threatening diseases and conditions. "We applaud President Obama for taking the first major step by issuing an Executive Order on March 9th overturning restrictions placed on federal funding of embryonic stem cell research. We look forward to working with Congress and the Administration to develop public policies that enable our industry to turn the hope of basic research to the reality of cures and advanced therapies." The guidelines can be viewed here. Biotechnology Industry Organization


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009